Comparative evaluation of α-galactosidase A infusions for treatment of Fabry disease
- 1 May 2003
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 5 (3), 144-153
- https://doi.org/10.1097/01.gim.0000069509.57929.cd
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Natural History and Treatment of Renal Involvement in Fabry DiseaseJournal of the American Society of Nephrology, 2002
- Fabry disease: 45 novel mutations in the α-galactosidase A gene causing the classical phenotypeMolecular Genetics and Metabolism, 2002
- Natural History of Fabry Renal DiseaseMedicine, 2002
- Patients with Fabry disease on dialysis in the United StatesKidney International, 2002
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier femalesJournal of Medical Genetics, 2001
- Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous malesJournal of Medical Genetics, 2001
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJama-Journal Of The American Medical Association, 2001
- A Phase 1/2 Clinical Trial of Enzyme Replacement in Fabry Disease: Pharmacokinetic, Substrate Clearance, and Safety StudiesAmerican Journal of Human Genetics, 2001
- Enzyme therapy for Gaucher disease: the first 5 yearsBlood Reviews, 1998